Deep learning frameworks allow blood glucose levels to be estimated directly from retinal images, reducing the need for traditional testing.
AI and machine learning transform ophthalmology, scanning the retina for powerful tools to predict health risks. Retinal images provide a non-invasive view of blood vessels and nerve fibers, indicating the risk of hypertension, kidney, heart, and stroke-related problems.
Techniques such as Fundus Photography and Optical Coherence Tomography (OCT-A) have made it possible to image detailed retinal blood vessels. Researchers use AI to analyze these images to identify microvascular biomarkers associated with systemic disease.
New approaches such as “ophthalmology” allow clinicians to predict surgical outcomes of macular hole treatment and assess risk levels for patients in multiple conditions in a single scan.
AI also applies to diabetes screening, especially in countries with significant risk populations. Deep learning frameworks can estimate average blood glucose levels (HBA1C) from retinal images and provide a non-invasive, cost-effective alternative to blood tests.
Despite that promise, ophthalmology AI is facing challenges. A limited, non-enormous data set can reduce accuracy, and the “black box” nature of AI decision-making can make doctors hesitate.
Collaborative efforts to share anonymous patient data and develop more transparent AI models will help overcome these hurdles, paving the way for safer and more reliable applications.
Want to learn more about AI, technology, and digital diplomacy? If so, ask our Diplo chatbot!
